Ming Ying

Title: Innovations by Ming Ying in the Treatment of Hyperphenylalaninemia

Introduction

Ming Ying is an accomplished inventor based in Zaragoza, Spain. He has made significant contributions to the field of pharmacology, particularly in the treatment of metabolic disorders. His innovative work focuses on developing compositions that address hyperphenylalaninemia, a condition that can lead to serious health issues if left untreated.

Latest Patents

Ming Ying holds a patent for "Compositions for the treatment of hyperphenylalaninemia." This invention relates to the use of specific types of compounds that act as pharmacological chaperones. These compounds have a stabilizing activity on the phenylalanine hydroxylase (PAH) enzyme, which is crucial for the prophylaxis and treatment of hyperphenylalaninemia (HPA) and phenylketonuria (PKU). The patent also covers pharmaceutical compositions containing these compounds and methods for treating HPA and related disorders.

Career Highlights

Ming Ying is affiliated with the Universidad de Zaragoza, where he conducts research and develops innovative solutions for metabolic disorders. His work has garnered attention for its potential to improve the quality of life for individuals affected by HPA and PKU. With a focus on practical applications, his research aims to bridge the gap between scientific discovery and clinical practice.

Collaborations

Ming Ying collaborates with notable colleagues, including Ángel Pey Rodríguez and Aurora Martínez Ruiz. These partnerships enhance the research efforts at the Universidad de Zaragoza, fostering an environment of innovation and discovery.

Conclusion

Ming Ying's contributions to the treatment of hyperphenylalaninemia exemplify the impact of innovative research in pharmacology. His patent and ongoing work hold promise for advancing therapeutic options for individuals with metabolic disorders.